Search reports.
APAC Artificial Organs & Bionic Implants Market Size | 2031
Get free sample report Request for Customiztion Buy Now

APAC Artificial Organs & Bionic Implants Market Size | 2031

Segments - Asia Pacific Artificial Organs & Bionic Implants Market by Products (Artificial Organs [Artificial Heart, Artificial Kidney, Artificial Liver, Cochlear Implants, and Others], Bionics [Vision Bionics, Ear Bionics, Orthopedic Bionic, and Cardiac Bionics]), and Geography (China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific) - Asia Pacific Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031

https://growthmarketreports.com/raksha
Author : Raksha Sharma
https://growthmarketreports.com/Vaibhav
Fact-checked by : V. Chandola
https://growthmarketreports.com/Vishal
Editor : Vishal Golekar

Upcoming | Report ID :HC-4536 | 4.9 Rating | 72 Reviews | 176 Pages | Format : PDF Excel PPT

Report Description


Asia Pacific Artificial Organs & Bionic Implants Market Outlook

The Asia Pacific artificial organs & bionic implant market size was valued at USD 6.49 Billion in 2022 and is estimated to reach USD 13.08 Billion by 2031, expanding at a CAGR of 8.1% during the forecast period, 2023–2031. The growth of the market is attributed to increasing incidence of disabilities.

The artificial organs and bionic are a human made devices that can be implanted or integrated in human body, either to provide support for purpose of restoring specific function or replacing the natural organs to help the patients to return to normal life.

The artificial and bionic organs can replicate the function of damaged organs. There are various parts of the body implanted such as limbs joints, eye, heart, liver, and lungs.

Asia Pacific Artificial Organs & Bionic Implants Market Outlook

The Covid-19 pandemic affected the demand and supply of the Asia pacific artificial organs and bionic implants market because of lockdown in various countries.

Lockdown across the globe, supply chain disorders, and oscillating supply of raw materials forced manufacturers to shut down production leading to unfortunate decline in market growth.

Launch of vaccines to combat the Covid-19 pandemic is expected to contribute to the market growth over the forecast period.

  • The research & development and technological advancement in the medical sector are estimated to drive the market during the forecast period.
  • Increasing incidence of disabilities is demanding the artificial organs and bionic implants organs. This is expected to drives the market.
  • Increasing geriatric population prone to organ failure is projected to drive the Asia pacific artificial organs and bionic implants market during the forecast period.
  • The cost of artificial organs and expensive procedures are hampering the market growth during the forecast period.
  • The fear about malfunction of device, its results and lack of specialist to carry out the procedure is hindering the artificial organs and bionic implants market.
  • Increasing development in artificial organs and bionic implants sector is estimated to fuel the market.

Scope of Asia Pacific Artificial Organs & Bionic Implants Market Report

The report on the Asia pacific artificial organs & bionic implants market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Artificial Organs & Bionic Implants Market - Asia Pacific Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2022

Historic Data

2016–2021

Forecast Period

2023–2031

Segmentation

Products (Artificial Organs [Artificial Heart, Artificial Kidney, Artificial Liver, Cochlear Implants, and Others], Bionics [Vision Bionics, Ear Bionics, Orthopedic Bionic, and Cardiac Bionics])

Geographical Scope

Asia Pacific

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Ossur; Boston Scientific Corporation; Otto Bock Holding GmbH & Co.KG; Medtronic plc; Zimmer Biomet

Asia Pacific Artificial Organs & Bionic Implants Market Segment Insights

Products Segment Analysis

Based on products, the Asia pacific artificial organs & bionic implants market is bifurcated into artificial organs and bionic. The artificial organs are further divided into artificial heart, artificial kidney, artificial liver, cochlear implants, and others. The bionic segment is further segmented into vision bionics, ear bionics, orthopedic bionic, and cardiac bionics.

The orthopedic bionic segment is projected to expand at a considerable CAGR during the forecast period because of increasing road accidents and injuries requiring amputation. In 2018, a total 4, 67,044 road accidents has been reported by the union territory in India. The China country has 63,194 accidental cases recorded by the national bureau of statistics of China, in 2018.

The Japan has 3,532 deaths due to road accidents recorded by the statistical bureau of Japan. Therefore, increasing road and transport injuries are projected to boost the market. However, the cochlear implant segment is anticipated to constitute a key market share during the forecast period because of increasing demand and low cost of the implantation.

Asia Pacific Artificial Organs & Bionic Implants Market Products

Asia Pacific Artificial Organs & Bionic Implants Market Segment Analysis

In terms of geography, the Asia pacific artificial organs and bionic implants divided into China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific. Japan is anticipated to constitute a key market share during the forecast period due to advancement in the technology in the country. On the other hand, India is also improving their medical sector because of increasing accidental cases.

Segments

Products

  • Artificial Organs
    • Artificial Heart
    • Artificial Kidney
    • Artificial Liver
    • Cochlear Implants
    • Others
  • Bionics
    • Vision Bionics
    • Ear Bionics
    • Orthopedic Bionic
    • Cardiac Bionics

Geography

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific

Key Players

  • Ossur
  • Boston Scientific Corporation
  • Otto Bock Holding GmbH & Co.KG
  • Medtronic plc.
  • Zimmer Biomet

Competitive Landscape

Key players competing in the Asia pacific artificial organs and bionic implants market include Ossur; Boston Scientific Corporation; Otto Bock Holding GmbH & Co.KG; Medtronic plc.; Zimmer Biomet.

These key players are constantly implementing several marketing strategies such as merger & acquisitions, capital investments, partnerships, and new product development to sustain industry position in the market.

Asia Pacific Artificial Organs & Bionic Implants Market Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Artificial Organs & Bionic Implants Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Artificial Organs & Bionic Implants Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Artificial Organs & Bionic Implants Market - Supply Chain
  4.5. Global Artificial Organs & Bionic Implants Market Forecast
     4.5.1. Artificial Organs & Bionic Implants Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Artificial Organs & Bionic Implants Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Artificial Organs & Bionic Implants Market Absolute $ Opportunity
5. Global Artificial Organs & Bionic Implants Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Artificial Organs & Bionic Implants Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Artificial Organs & Bionic Implants Demand Share Forecast, 2019-2026
6. North America Artificial Organs & Bionic Implants Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Artificial Organs & Bionic Implants Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Artificial Organs & Bionic Implants Demand Share Forecast, 2019-2026
7. Latin America Artificial Organs & Bionic Implants Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Artificial Organs & Bionic Implants Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Artificial Organs & Bionic Implants Demand Share Forecast, 2019-2026
8. Europe Artificial Organs & Bionic Implants Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Artificial Organs & Bionic Implants Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Artificial Organs & Bionic Implants Demand Share Forecast, 2019-2026
9. Asia Pacific Artificial Organs & Bionic Implants Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Artificial Organs & Bionic Implants Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Artificial Organs & Bionic Implants Demand Share Forecast, 2019-2026
10. Middle East & Africa Artificial Organs & Bionic Implants Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Artificial Organs & Bionic Implants Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Artificial Organs & Bionic Implants Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Artificial Organs & Bionic Implants Market: Market Share Analysis
  11.2. Artificial Organs & Bionic Implants Distributors and Customers
  11.3. Artificial Organs & Bionic Implants Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Ossur
     11.4.2. Boston Scientific Corporation
     11.4.3. Otto Bock Holding GmbH & Co.KG
     11.4.4. Medtronic plc.
     11.4.5. Zimmer Biomet

Methodology

Our Clients

Siemens Healthcare
Nestle SA
Pfizer
Deloitte
Microsoft
Honda Motor Co. Ltd.
FedEx Logistics
General Mills